References

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

10.3322/caac.21834 · 2024 · External reference

Predictors of early and late hepatocellular carcinoma recurrence

10.3748/wjg.v29.i8.1243 · 2023 · External reference

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma

10.1016/j.jhep.2024.08.028 · 2025 · External reference

China liver cancer guidelines for the diagnosis and treatment of hepatocellular carcinoma (2024 edition)

10.1159/000546574 · 2025 · External reference

Milestones in the treatment of hepatocellular carcinoma: A systematic review

10.1016/j.critrevonc.2020.103179 · 2021 · External reference

Hepatocellular carcinoma

10.1016/s0140-6736(22)01200-4 · 2022 · External reference

Tumor-associated macrophages in liver cancer: From mechanisms to therapy

10.1002/cac2.12345 · 2022 · External reference

Tumor‐associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells

10.1053/j.gastro.2014.08.039 · 2014 · External reference

Tumor-associated macrophages in hepatocellular carcinoma: friend or foe

10.5009/gnl20223 · 2021 · External reference

Obesity drives STAT-1-dependent NASH and STAT-3-dependent HCC

10.1016/j.cell.2018.09.053 · 2018 · External reference

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma

10.1016/j.apsb.2021.09.019 · 2022 · External reference

Drilling for oil: tumor-surrounding adipocytes fueling cancer

10.1016/j.trecan.2020.03.001 · 2020 · External reference

Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies

10.1016/j.canlet.2024.217061 · 2024 · External reference

Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation

10.1186/s12943-018-0838-5 · 2018 · External reference

Landscape and dynamics of single immune cells in hepatocellular carcinoma

10.1016/j.cell.2019.10.003 · 2019 · External reference

The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma

10.1002/hep.32740 · 2023 · External reference

CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor

10.1038/s41421-023-00529-z · 2023 · External reference

Lipid metabolism-related gene signature predicts prognosis and indicates immune microenvironment infiltration in advanced gastric cancer

10.1155/2024/6639205 · 2024 · External reference

Integrated analysis of multimodal single-cell data

10.1016/j.cell.2021.04.048 · 2021 · External reference

ReactomeGSA: new features to simplify public data reuse

10.1093/bioinformatics/btae338 · 2024 · External reference

Translation and Adaptation of the Adult Developmental Coordination Disorder/Dyspraxia Checklist (ADC) into Asian Uzbekistan

10.3390/sports11070135 · 2023 · External reference

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

10.1186/s13059-014-0550-8 · 2014 · External reference

ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2

10.1093/bioinformatics/btac409 · 2022 · External reference

Complex heatmaps reveal patterns and correlations in multidimensional genomic data

10.1093/bioinformatics/btw313 · 2016 · External reference

UpSetR: an R package for the visualization of intersecting sets and their properties

10.1093/bioinformatics/btx364 · 2017 · External reference

clusterProfiler: an R package for comparing biological themes among gene clusters

10.1089/omi.2011.0118 · 2012 · External reference

Clinicopathological characteristics of pheochromocytoma/paraganglioma and screening of prognostic markers

10.1002/jso.27358 · 2023 · External reference

Applying logistic LASSO regression for the diagnosis of atypical Crohn's disease

10.1038/s41598-022-15609-5 · 2022 · External reference

Time-dependent ROC curve analysis in medical research: current methods and applications

10.1186/s12874-017-0332-6 · 2017 · External reference

Efflux of N1-acetylspermidine from hepatoma fosters macrophage-mediated immune suppression to dampen immunotherapeutic efficacy

10.1016/j.immuni.2025.05.006 · 2025 · External reference

GSVA: gene set variation analysis for microarray and RNA-seq data

10.1186/1471-2105-14-7 · 2013 · External reference

Unveiling cuproptosis-driven molecular clusters and immune dysregulation in ankylosing spondylitis

10.2147/jir.s502520 · 2025 · External reference

Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade

10.1016/j.celrep.2016.12.019 · 2017 · External reference

Inferring tumour purity and stromal and immune cell admixture from expression data

10.1038/ncomms3612 · 2013 · External reference

Classification of triple-negative breast cancers based on Immunogenomic profiling

10.1186/s13046-018-1002-1 · 2018 · External reference

An immune-related signature based on molecular subtypes for predicting the prognosis and immunotherapy efficacy of hepatocellular carcinoma

10.3389/fimmu.2025.1481366 · 2025 · External reference

Epigenetics in hepatocellular carcinoma

10.1016/j.semcancer.2021.07.017 · 2022 · External reference

Inference and analysis of cell-cell communication using CellChat

10.1038/s41467-021-21246-9 · 2021 · External reference

Potential tumor-specific antigens and immune landscapes identification for mRNA vaccine in thyroid cancer

10.3389/fonc.2024.1480028 · 2024 · External reference

Correlation analysis of mitochondrial DNA maintenance-related genes with HCC prognosis, tumor mutation burden and tumor microenvironment features

10.1371/journal.pone.0325033 · 2025 · External reference

Lysine-specific demethylase 1 deletion reshapes tumour microenvironment to overcome acquired resistance to anti-programmed death 1 therapy in liver cancer

10.1002/ctm2.70335 · 2025 · External reference

Implications of genetic heterogeneity in hepatocellular cancer

10.1016/bs.acr.2022.01.007 · 2022 · External reference

A novel immune-related genes prognosis biomarker for hepatocellular carcinoma

10.18632/aging.202173 · 2020 · External reference

Predictive models for HCC prognosis, recurrence risk, and immune infiltration based on two exosomal genes: MYL6B and THOC2

10.2147/jir.s315957 · 2021 · External reference

Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma

10.1136/jitc-2019-000501 · 2020 · External reference

Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells

10.1038/s42003-020-01367-5 · 2020 · External reference

Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring

10.1038/s42255-024-01019-6 · 2024 · External reference

Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation

10.1126/sciimmunol.add8945 · 2023 · External reference

Hypoxic tumor-derived exosomal miR-4488 induces macrophage M2 polarization to promote liver metastasis of pancreatic neuroendocrine neoplasm through RTN3/FABP5 mediated fatty acid oxidation

10.7150/ijbs.96831 · 2024 · External reference

FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity

10.1016/j.jhep.2024.09.029 · 2025 · External reference

Mitochondrial integrity regulated by lipid metabolism is a cell-intrinsic checkpoint for Treg suppressive function

10.1016/j.cmet.2019.11.021 · 2020 · External reference

CRISPR/Cas9 screens reveal that hexokinase 2 enhances cancer stemness and tumorigenicity by activating the ACSL4-fatty acid β-oxidation pathway

10.1002/advs.202105126 · 2022 · External reference

Knockdown of ECHS1 protein expression inhibits hepatocellular carcinoma cell proliferation via suppression of Akt activity

10.1615/critreveukaryotgeneexpr.2013007531 · 2013 · External reference

Comprehensive analysis of chronic hepatitis B concurrent with non-alcoholic fatty liver disease: a proteomics report based on clinical liver samples

10.1186/s12014-024-09523-3 · 2025 · External reference

Silencing ECHS1 attenuates the proliferation and induces the autophagy of hepatocellular carcinoma via impairing cell metabolism and activating AMPK

10.4149/neo_2015_106 · 2015 · External reference

ECHS1 acts as a novel HBsAg-binding protein enhancing apoptosis through the mitochondrial pathway in HepG2 cells

10.1016/j.canlet.2012.11.030 · 2013 · External reference

The role of PPARs in disease

10.3390/cells9112367 · 2020 · External reference

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of hepatocellular carcinoma (HCC)

10.1016/j.biopha.2024.117089 · 2024 · External reference

The role of PPAR alpha in the modulation of innate immunity

10.3390/ijms221910545 · 2021 · External reference

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma

10.1136/gutjnl-2022-328364 · 2023 · External reference

Fatty acid metabolism affects hepatocellular carcinoma progression via the PPAR-γ signaling pathway and fatty acid β-oxidation

10.1016/j.intimp.2024.112917 · 2024 · External reference

Hepatocarcinogenesis prevention by Pirfenidone is PPARγ mediated and involves modification of nuclear NF-kB p65/p50 ratio

10.3390/ijms222111360 · 2021 · External reference

Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy

10.1172/jci.insight.163624 · 2023 · External reference

CRSP8-driven fatty acid metabolism reprogramming enhances hepatocellular carcinoma progression by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling

10.1186/s13046-025-03329-3 · 2025 · External reference

Formononetin promotes fatty acid β-oxidation to treat non-alcoholic steatohepatitis through SIRT1/PGC-1α/PPARα pathway

10.1016/j.phymed.2023.155285 · 2024 · External reference

Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)

10.1016/j.phrs.2023.106786 · 2023 · External reference

CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways

10.1016/j.jhep.2015.07.039 · 2015 · External reference

MARCH8 suppresses hepatocellular carcinoma by promoting SREBP1 degradation and modulating fatty acid de novo synthesis

10.1038/s41419-025-07707-9 · 2025 · External reference

TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation

10.1038/s41388-024-03056-7 · 2024 · External reference

Sodium butyrate increases USP5-mediated ubiquitination degradation of GPX4 and enhances anti-cancer efficacy of anti-PD-1 antibody

10.1016/j.bcp.2025.116927 · 2025 · External reference

AF6 knockout-induced upregulation of bile acid production promotes CXCL14-mediated antitumor immunity in HCC

10.1016/j.jhep.2025.12.029 · 2026 · External reference

Improvement of mTORC1-driven overproduction of apoB-containing triacylglyceride-rich lipoproteins by short-chain fatty acids, 4-phenylbutyric acid and (R)-α-lipoic acid, in human hepatocellular carcinoma cells

10.1016/j.bbalip.2015.12.001 · 2016 · External reference

Understanding the tumor immune microenvironment (TIME) for effective therapy

10.1038/s41591-018-0014-x · 2018 · External reference

Cold and hot tumors: from molecular mechanisms to targeted therapy

10.1038/s41392-024-01979-x · 2024 · External reference

Dendritic cells in the cancer microenvironment

10.7150/jca.5046 · 2013 · External reference

Molecular and cellular insights into T cell exhaustion

10.1038/nri3862 · 2015 · External reference

The role of fibroblasts in pancreatic cancer: Extracellular matrix versus paracrine factors

10.1016/j.tranon.2017.04.009 · 2017 · External reference

Cancer-associated fibroblasts suppress CD8+ T-cell infiltration and confer resistance to immune-checkpoint blockade

10.1158/0008-5472.can-21-4141 · 2022 · External reference

Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis

10.1002/hep.22698 · 2009 · External reference

miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1)

10.1186/s12885-016-2801-4 · 2016 · External reference

Combined identification of ARID1A, CSMD1, and SENP3 as effective prognostic biomarkers for hepatocellular carcinoma

10.18632/aging.202586 · 2021 · External reference

Hypoxia induces hepatocellular carcinoma metastasis via the HIF-1α/METTL16/lnc-CSMD1-7/RBFOX2 axis

10.1016/j.isci.2023.108495 · 2023 · External reference

Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2

10.1038/42523 · 1997 · External reference

Single-cell RNA-seq reveals the immune cell landscape and cell-cell communications in childhood Sjögren’s disease

10.1038/s42003-024-06123-x · 2024 · External reference

Deciphering the role of tryptophan metabolism-associated genes ECHS1 and ALDH2 in gastric cancer: implications for tumor immunity and personalized therapy

10.3389/fimmu.2024.1460308 · 2024 · External reference

Tumor-infiltrating CD8+ T-cell numbers and serum C-reactive protein levels as a prognostic biomarker in hepatocellular carcinoma patients receiving atezolizumab plus bevacizumab

10.1111/hepr.14100 · 2025 · External reference

From genes to therapy: a lipid metabolism-related genetic risk model predicts HCC outcomes and enhances immunotherapy

10.1186/s12885-025-14306-6 · 2025 · External reference

Development of a novel CD8+ T cell-associated signature for prognostic assessment in hepatocellular carcinoma

10.1177/10732748241270583 · 2024 · External reference